Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-22.76M
↓ 39% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-16.39M
Historical baseline
PeriodValueYoY Change
TTM$-22.76M+23.9%
2024$-29.92M+23.8%
2023$-39.26M-61.3%
2022$-24.34M-185.6%
2021$-8.52M-125.2%
2020$-3.78M-346.8%
2019$-846832.00+49.6%
2018$-1.68M-